← FDA Drug Approvals (Drugs@FDA)
ZIPRASIDONE MESYLATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2022-09-15
Drug application
- FDA Application #
ANDA216091- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ZIPRASIDONE MESYLATE
- Generic name
- ZIPRASIDONE MESYLATE
- Active ingredients
- ZIPRASIDONE MESYLATE
- Dosage form
- POWDER
- Route
- INTRAMUSCULAR
- Marketing status
- Prescription
- Sponsor
- MSN
- Manufacturer
- Novadoz Pharmaceuticals LLC
- First approval
- 2022-09-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown